JADDP 2012-004 JADA vs J-4135

In September 2012 the Japan Anti-Doping Agency (JADA) has reported an anti-doping rule violation against the Athlete J-4135 (the Athlete) after his sample tested positive for the prohibited substance furosemide. After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Japan Anti-Doping Disciplinary Panel.

The Athlete stated that he has used a herbal medication purchased on the internet as treatment for his insomnia.
Considering the Athlete's negligence and his statement the Japan Anti-Doping Disciplinary Panel has his doubts that the use was non intentional and decides on 28 September 2012 to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 18 September 2012.

Original document

Parameters

Legal Source
National Decisions
Date
28 September 2012
Arbitrator
Hayakawa, Yoshihisa
Mesaki, Noboru
Tsukagoshi, Katsumi
Original Source
Japan Anti-Doping Agency (JADA)
Country
Japan
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Negligence
Sport/IFs
Bodybuilding & Fitness (IFBB) - International Federation of Bodybuilding & Fitness
Other organisations
Japan Anti-Doping Agency (JADA)
Japan Anti-Doping Disciplinary Panel (JADDP)
Laboratories
Tokyo, Japan: Anti-Doping Laboratory
Doping classes
S5. Diuretics and Other Masking Agents
Substances
Furosemide
Medical terms
Treatment / self-medication
Various
Supplements
Document type
Pdf file
Date generated
31 August 2016
Date of last modification
3 September 2018
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin